PE46699A1 - Compuesto derivado de indol - Google Patents
Compuesto derivado de indolInfo
- Publication number
- PE46699A1 PE46699A1 PE1997000586A PE00058697A PE46699A1 PE 46699 A1 PE46699 A1 PE 46699A1 PE 1997000586 A PE1997000586 A PE 1997000586A PE 00058697 A PE00058697 A PE 00058697A PE 46699 A1 PE46699 A1 PE 46699A1
- Authority
- PE
- Peru
- Prior art keywords
- sub
- alkyl
- optionally substituted
- group
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
- -1 hydroxy, amino Chemical group 0.000 abstract 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9614367.2A GB9614367D0 (en) | 1996-07-09 | 1996-07-09 | Novel compounds |
| GBGB9626700.0A GB9626700D0 (en) | 1996-12-23 | 1996-12-23 | Novel compounds |
| GBGB9626697.8A GB9626697D0 (en) | 1996-12-23 | 1996-12-23 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE46699A1 true PE46699A1 (es) | 1999-06-12 |
Family
ID=27268385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000586A PE46699A1 (es) | 1996-07-09 | 1997-07-07 | Compuesto derivado de indol |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20020173659A1 (fr) |
| EP (1) | EP0914321B1 (fr) |
| JP (1) | JP2000514074A (fr) |
| KR (1) | KR20000023646A (fr) |
| AT (1) | ATE277037T1 (fr) |
| AU (1) | AU3620597A (fr) |
| BR (1) | BR9710230A (fr) |
| CA (1) | CA2259598A1 (fr) |
| CZ (1) | CZ3799A3 (fr) |
| DE (1) | DE69730837T2 (fr) |
| ES (1) | ES2229375T3 (fr) |
| ID (1) | ID18181A (fr) |
| IL (1) | IL127668A0 (fr) |
| MA (1) | MA24349A1 (fr) |
| NO (1) | NO990080L (fr) |
| PE (1) | PE46699A1 (fr) |
| PL (1) | PL330994A1 (fr) |
| TR (1) | TR199900138T2 (fr) |
| TW (1) | TW397684B (fr) |
| UY (2) | UY24608A1 (fr) |
| WO (1) | WO1998001443A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998037070A1 (fr) * | 1997-02-21 | 1998-08-27 | Takeda Chemical Industries, Ltd. | Composes a anneaux condenses, leur procede de production et leur utilisation |
| EA005932B1 (ru) * | 1998-05-15 | 2005-08-25 | Уайт | 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами |
| US6479535B1 (en) | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| GB9914371D0 (en) * | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| SE9903610D0 (sv) * | 1999-10-06 | 1999-10-06 | Astra Ab | Novel compounds II |
| SE9903611D0 (sv) * | 1999-10-06 | 1999-10-06 | Astra Ab | Novel compounds III |
| SE9903760D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
| DE10022925A1 (de) * | 2000-05-11 | 2001-11-15 | Basf Ag | Substituierte Indole als PARP-Inhibitoren |
| EP1303265B1 (fr) | 2000-07-20 | 2007-07-11 | Lauras AS | Utilisation d'inhibiteurs de cox-2 en tant qu'immunostimulants dans le traitement du vih ou du sida |
| EP1373204B1 (fr) | 2001-03-09 | 2016-10-26 | Janssen Pharmaceuticals, Inc. | Composes heterocycliques |
| JP2005510482A (ja) * | 2001-10-16 | 2005-04-21 | アストラゼネカ・アクチエボラーグ | 線維筋痛症候群の治療方法 |
| WO2004022060A2 (fr) | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Composes heterocycliques |
| RU2315767C2 (ru) * | 2002-11-25 | 2008-01-27 | Ф.Хоффманн-Ля Рош Аг | Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний |
| US6916852B2 (en) * | 2003-05-12 | 2005-07-12 | University Of Tennessee Research Foundation | Method for regulation of microvascular tone |
| ITMI20040875A1 (it) * | 2004-04-30 | 2004-07-30 | Ist Naz Stud Cura Dei Tumori | Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali |
| EP1779848A1 (fr) | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | Inhibiteurs de la V-ATPase pour le traitement des maladies inflammatoires et autoimmunes |
| EP1779849A1 (fr) | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | inhibiteurs de V-ATPase pour le traitement du choc septique |
| WO2010144611A2 (fr) * | 2009-06-10 | 2010-12-16 | 3-V Biosciences, Inc. | Antiviraux qui ciblent des transporteurs, des protéines porteuses et des canaux ioniques |
| WO2012045451A1 (fr) | 2010-10-05 | 2012-04-12 | Ludwig-Maximilians-Universitaet Muenchen | Nouveau traitement thérapeutique de maladies dépendantes de la progranuline |
| EP2739144A4 (fr) * | 2011-06-20 | 2015-04-01 | Alzheimer S Inst Of America Inc | Composés et ses utilisations thérapeutiques |
| US20230219881A1 (en) * | 2022-01-11 | 2023-07-13 | Compound Solutions Inc. | Synthesis of Spermidine, Spermine, and Free Bases Thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2038925A1 (fr) * | 1990-03-26 | 1991-09-27 | Takashi Sohda | Derives d'indole; preparation et utilisation |
| WO1993001280A1 (fr) * | 1991-07-08 | 1993-01-21 | Roland Baron | Inhibition de pompe protonique dans des cellules osteoclastiques |
| JPH07223945A (ja) * | 1994-02-10 | 1995-08-22 | Snow Brand Milk Prod Co Ltd | 骨疾患治療剤 |
| US5981525A (en) * | 1995-01-10 | 1999-11-09 | Smithkline Beecham Corporation | Indole derivatives useful in the treatment of osteoporosis |
-
1997
- 1997-07-03 WO PCT/EP1997/003577 patent/WO1998001443A1/fr not_active Ceased
- 1997-07-03 CZ CZ9937A patent/CZ3799A3/cs unknown
- 1997-07-03 PL PL97330994A patent/PL330994A1/xx unknown
- 1997-07-03 AT AT97932778T patent/ATE277037T1/de not_active IP Right Cessation
- 1997-07-03 AU AU36205/97A patent/AU3620597A/en not_active Abandoned
- 1997-07-03 JP JP10504784A patent/JP2000514074A/ja not_active Ceased
- 1997-07-03 DE DE69730837T patent/DE69730837T2/de not_active Expired - Lifetime
- 1997-07-03 BR BR9710230A patent/BR9710230A/pt not_active IP Right Cessation
- 1997-07-03 EP EP97932778A patent/EP0914321B1/fr not_active Expired - Lifetime
- 1997-07-03 TR TR1999/00138T patent/TR199900138T2/xx unknown
- 1997-07-03 CA CA002259598A patent/CA2259598A1/fr not_active Abandoned
- 1997-07-03 ES ES97932778T patent/ES2229375T3/es not_active Expired - Lifetime
- 1997-07-03 IL IL12766897A patent/IL127668A0/xx unknown
- 1997-07-07 PE PE1997000586A patent/PE46699A1/es not_active Application Discontinuation
- 1997-07-07 ID IDP972341A patent/ID18181A/id unknown
- 1997-07-07 MA MA24706A patent/MA24349A1/fr unknown
- 1997-07-07 UY UY24608A patent/UY24608A1/es unknown
- 1997-07-08 TW TW086109710A patent/TW397684B/zh not_active IP Right Cessation
- 1997-12-05 UY UY24802A patent/UY24802A1/es unknown
-
1999
- 1999-01-08 KR KR1019997000099A patent/KR20000023646A/ko not_active Withdrawn
- 1999-01-08 NO NO990080A patent/NO990080L/no not_active Application Discontinuation
-
2001
- 2001-12-04 US US10/005,491 patent/US20020173659A1/en not_active Abandoned
-
2002
- 2002-11-20 US US10/300,332 patent/US6903117B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2259598A1 (fr) | 1998-01-15 |
| MA24349A1 (fr) | 1998-07-01 |
| WO1998001443A1 (fr) | 1998-01-15 |
| EP0914321A1 (fr) | 1999-05-12 |
| KR20000023646A (ko) | 2000-04-25 |
| ES2229375T3 (es) | 2005-04-16 |
| UY24608A1 (es) | 1997-12-19 |
| UY24802A1 (es) | 2001-03-16 |
| JP2000514074A (ja) | 2000-10-24 |
| ATE277037T1 (de) | 2004-10-15 |
| DE69730837D1 (de) | 2004-10-28 |
| US6903117B2 (en) | 2005-06-07 |
| AU3620597A (en) | 1998-02-02 |
| ID18181A (id) | 1998-03-12 |
| BR9710230A (pt) | 1999-08-10 |
| IL127668A0 (en) | 1999-10-28 |
| NO990080D0 (no) | 1999-01-08 |
| PL330994A1 (en) | 1999-06-21 |
| US20020173659A1 (en) | 2002-11-21 |
| TR199900138T2 (xx) | 1999-04-21 |
| DE69730837T2 (de) | 2005-09-29 |
| TW397684B (en) | 2000-07-11 |
| NO990080L (no) | 1999-01-08 |
| EP0914321B1 (fr) | 2004-09-22 |
| CZ3799A3 (cs) | 1999-08-11 |
| US20040010012A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE46699A1 (es) | Compuesto derivado de indol | |
| BG101769A (en) | Indole derivatives useful in the treatment of osteoporosis | |
| MX9804107A (es) | Derivados de quinolina. | |
| GEP19970661B (en) | Process for preparing arylcyclobutyl alkylamine derivatives | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| KR960701055A (ko) | 인터로이킨-1 및 종양 괴사 인자 억제 활성을 지닌 피라졸로트리아진 (pyrazol itriazines with interleukin-1 and tumour necrosis factor in-hibitory actvity) | |
| MXPA02011974A (es) | Derivados de quinazolina sustituidos y su uso como inhibidores. | |
| AU6052594A (en) | New heterocyclic compounds | |
| ES2133543T3 (es) | Derivados de pirrolidina y oxazolidina, su preparacion y su uso como inhibidores de la agregacion de trombocitos. | |
| HUT60464A (en) | Process for producing n-phenylbenzamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| NZ505060A (en) | 2-Aryl or heterocyclyl substituted indole derivatives useful for the treatment of osteoporosis | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
| ATE234818T1 (de) | Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| AU693241B2 (en) | New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments | |
| ATE149159T1 (de) | Heteroarylmethylbenzole-aromatasehemmer | |
| GR3033333T3 (en) | Carbamoyl carboxylic acid amides | |
| AU567718B2 (en) | 5-amino-1,2-dithiol-3-one derivatives | |
| NZ275620A (en) | 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions | |
| DK0646113T3 (fr) | ||
| MY108027A (en) | Substitute tetrahydroisoquinolines and use as therepuetic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |